Magnetic nanoparticles are widely used in biomedical applications [1] [2] [3] . However, the biocompatibility of chemically synthesized magnetic nanoparticles (MNPs) usually must be improved by complicated chemical modifications. Bacterial magnetosomes (BMs), a type of biosynthesized magnetic nanoparticle, have attracted great interest due to their unique nanostructure, encapsulation by a biomolecular membrane, and narrow size distribution 4 . BMs have been investigated for use in medical and diagnostic applications, such as magnetic resonance imaging (MRI), drug delivery, and hyperthermia [5] [6] [7] . In contrast to chemically synthesized MNPs, BMs are synthesized by magnetotactic bacteria and are generally composed of Fe 3 O 4 or Fe 3 S 4 , with a size range of 30 to 120 nm 8 . Large-scale culture of Magnetospirillum gryphiswaldense MSR-1 has made high-yield and low-cost production of Fe 3 O 4 -containing BMs feasible 9 . The eye is a fragile organ and is protected by the blood-ocular barrier, which is created by the endothelium of the capillaries of the retina and iris, ciliary epithelium and retinal pigment epithelium. However, the blood-ocular barrier also prevents most drugs from entering the eye and hinders targeted medical therapies (e.g., ocular tumor-related treatments) 10 . Han et al. 11 reported that BMs can pass through the blood-brain barrier, which is similar in structure and function to the blood-ocular barrier, and carry genes to treat brain tumors. Intravitreal
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The biocompatibility of BMs must be assessed prior to use in ophthalmology applications, but studies of the biocompatibility of BMs have been limited. In a preliminary study, Sun et al. 14 demonstrated that BMs induced little pathological damage in important organs in rats and little cytotoxicity against H22, HL60 and EMT-6 cells. Liu et al. 15 reported that BMs mainly accumulated in the rat spleen and liver and were completely excreted in 42 days. The ocular biocompatibility of BMs has not been reported. Human ocular exposure to BMs is unavoidable, particularly among patients using BM-based medicines and workers handling these materials and the wastes of BM products, emphasizing the importance of evaluating the ocular biocompatibility of BMs. Here, we perform a detailed study of the biocompatibility of BMs in terms of both intraocular cytotoxicity and genotoxicity. For comparison, commercial MNPs with similar morphologies, sizes and surface groups were also evaluated as a control.
Results and Discussion
Characterization of BMs and MNPs. BMs were isolated from MSR-1. The UV absorption of the extracted supernatants at 260 and 280 nm decreased at each step until they reached zero (Fig. S1a) , and no proteins were detected at the fifth step by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Fig. S1b) , indicating that the BMs were free from other cellular protein fractions. However, "hard" membrane proteins were abundant in the BM membranes, indicating the presence of magnetosome membranes (Fig. S1 ). By contrast, protein was not detected on the surface of MNPs by SDS-PAGE (Fig. S1c) .
The surfaces and cores of the BMs and MNPs were further characterized by Fourier transform infrared spectroscopy (FTIR), zeta potential, magnetic hysteresis curves and high-resolution transmission electron microscopy (HRTEM). The MNPs were coated by organic layers containing amino groups (SIGMA-ALDRICH, CAS 1317-61-9). The FTIR spectra (Fig. 1a) indicated that the BMs and MNPs were both Fe-O-based materials (585 cm ) embedded with amino groups (1020-1360 cm −1 and 1550-1660 cm −1 ). However, the BMs had two additional peaks at 1739 and 1540 cm −1 , corresponding to carbonyl and amide groups, respectively. The zeta potentials of the BMs and MNPs were − 24.03 ± 0.1 and − 13.5 ± 0.3, respectively (Fig. 1b) . The magnetic hysteresis curves of the BMs and MNPs were obviously different (Fig. S2, Fig. 1b) . The curves indicated that the BMs were typical, single-domain magnetite, with a coercivity (Hc) value of 16.91 mT (greater than 0) and a saturation magnetization (Ms) value of 7.31 μ Am 2 . However, the Hc value of the MNPs was close to 0, indicating that the MNPs were intermediate between single-domain magnetite and super paramagnetic. We further observed the BMs and MNPs by HRTEM. The BMs were subspheroidal, and the MNPs were spherical; both displayed good dispersity and similar particle diameters (approximately 30 nm) (Fig. 1c,d ). for BM-treated cells. When the incubation time was extended to 96 h, the BM-treated ARPE-19 cells continued to undergo cell division (Fig. S3 ), but only fragments of MNP-treated cells were observed. These results suggest that the MNPs were more cytotoxic than BMs against ARPE-19 cells. The BMs and MNPs were both scattered in the cytoplasm, with no organelle specificity.
Cytotoxicity of BMs and MNPs. Cell morphology (TEM)
Cell viability. The cell viability of ARPE-19 cells in the presence of BMs or MNPs in the culture medium was determined by detecting the activities of intracellular dehydrogenases (CCK-8 assay) and membrane integrity (LDH test). BMs strikingly promoted the growth of ARPE-19 cells after 24 h of incubation (Fig. 3a) . The cell survival rate was greater than 90%, even after incubation with 100 μ g/mL BMs for 72 h, with an IC50 of 146 mg/mL. In addition, the BMs also strongly promoted the viability of other ocular cells, such as the cone cell line 661W (Fig. S4 ). The survival rates of ARPE-19 cells significantly decreased with increasing MNP concentrations and culture times. As shown in Fig. 3b , the cell survival rate was less than 50% after incubation with 100 μ g/mL MNPs for 72 h, and the IC50 was 95.7 μ g/mL.
Furthermore, the results of the LDH assay indicated that the BMs did not induce of LDH in ARPE-19 cells within 24 h, based on the negative values observed in the LDH test. However, after exposure for 24, 48 or 72 h, LDH levels were significantly higher in MNP-treated cells than in control cells, even at a concentration of 10 μ g/mL (Fig. 3d) . By contrast, the BMs had a negligible influence on LDH leakage (Fig. 3c) . These results indicate that the cytotoxicity of the BMs was much lower than that of the MNPs.
Genotoxicity of BMs and MNPs. Induction of DNA damage in ARPE-19 cells by BMs or MNPs.
The induction of DNA damage by BMs or MNPs in ARPE-19 cells was assessed by the alkaline Comet Assay (Fig. S5 ). According to the DNA damage tail percentage in ARPE-19 cells (Fig. 4) , both BMs and MNPs induced DNA damage in ARPE-19 cells. However, MNPs caused greater DNA damage than BMs; the tail percentage at 100 μ g/mL MNPs was twofold higher than that for cells treated with BMs at the same concentration (Fig. 4) .
ROS levels.
Excess reactive oxygen species (ROS) induce oxidative stress, one of the most important causes of DNA damage in cells 16 . Exposure to BMs and MNPs induced oxidative stress in ARPE-19 cells (Fig. 5) , and the level of ROS production increased with increasing concentrations of BMs or MNPs. However, ROS levels did not increase with BM exposure time. For example, when treated with 100 μ g/mL BMs for 24 h, the ROS level in the BM-treated cells was 1.7-fold higher than in the control. At longer incubation times of 48 and 72 h, ROS levels were 1.85-and 2-fold higher, respectively, than in the control, but these increases with time were not significant. ROS levels were 1.5-fold higher in 100 μ g/mL MNP-treated cells than in BM-treated cells at 72 h (Fig. S6 ). In the positive control (normal cells cultured with medium containing 500 mM H 2 O 2 for 30 min), the ROS level was 4.97-fold higher than in the control (data not shown), much higher than the ROS levels in BM-and MNP-treated cells under the same conditions. Cell apoptosis. The apoptotic and necrotic rates of BM-and MNP-treated ARPE-19 cells were further studied by fluorescence-activated cell sorting (FACS) after staining of dead and apoptotic cells with propidium iodide (PI) and Annexin V-FITC, respectively. As shown in Fig. S7 , cells undergoing the early stage of apoptosis were observed in the lower right section (PI − /FITC + ), indicating the release of the phospholipid phosphatidylserine (PS). The cells in the upper right section were PI + /FITC + and correspond to the end stage of apoptosis, necrosis or dead cells. The rates of apoptosis of MNP-treated cells were much higher than those of BM-treated cells (Fig. 6 ). For example, the apoptosis rate of ARPE-19 cells treated with 100 μ g/mL MNPs was 1.28%, nearly 3 times that of the control and cells treated with an identical concentration of BMs. Moreover, the MNPs also significantly increased the rate of necrosis. For example, 100 μ g/mL MNPs induced necrosis in 3.44% of cells, a rate fourfold higher than that induced by BMs. Based on the results of Comet assays and ROS detection, both BMs and MNPs induce ROS-dependent DNA damage, leading to apoptosis and necrosis of ARPE-19 cells. Compared with the MNPs, the BMs exhibited much weaker genotoxicity. The levels of apoptosis-related proteins were further determined by western blotting. Bcl-2 and Bax suppress and facilitate apoptosis, respectively. Knudson et al. 17 observed that a single copy of Bax promoted apoptosis, whereas overexpression of Bcl-2 still repressed apoptosis. As shown in Fig. 7 , Bcl-2 protein expression was significantly increased in BM-treated cells; this increase may suppress apoptosis in a variety of cells 18 . However, Bax protein expression was higher in MNP-treated cells than in BM-treated cells; this increase may accelerate programmed cell death by binding to and antagonizing the apoptosis repressor Bcl-2 18 . Furthermore, the ratios of Bcl-2 and Bax expression were opposing in BM-and MNP-treated cells. Both BMs and MNPs induced apoptosis in ARPE-19 cells; however, the BM-treated cells tended to suppress apoptosis progression and returned to normal conditions, whereas the MNP-treated cells entered late apoptosis, and apoptosis progression could not be suppressed. These results further indicate that the BMs were less cytotoxic than the MNPs. 
Conclusions
The cytotoxicity and genotoxicity of BMs and MNPs with similar morphologies, surface groups and size characteristics in ARPE-19 cells were investigated for the first time. Both BMs and MNPs entered ARPE-19 cells by endocytosis. BM-treated cells maintained normal cell morphology for up to 72 h, whereas most of the MNP-treated cells appeared to undergo autolysis. The BMs affected the cell survival rate and cell membrane integrity slightly, whereas a high concentration of MNPs significantly decreased the survival rate of ARPE-19 cells, as supported by both CCK-8 and LDH tests. The BMs and MNPs both featured surface amino groups. However, the BM membrane had extra carboxyl and amide groups, which enhanced the hydrophilicity and biocompatibility of the BMs. In addition, both BMs and MNPs induced DNA damage. However, DNA damage due to increased ROS production was reduced in BM-treated cells compared to MNP-treated cells. The BMs and MNPs also induced apoptosis, but the high concentration of MNPs caused obvious cell necrosis. Western blot analysis revealed that the BMs significantly induced the expression of Bcl-2 and the MNPs significantly induced the expression of Bax. Bcl-2 and Bax suppress and facilitate apoptosis, respectively. Therefore, both BMs and MNPs caused DNA damage in ARPE-19 cells, but the damage caused by the BMs was controllable and limited and could be reversed by cellular self-repair. By contrast, the DNA damage caused by the MNPs was serious and difficult to repair; thus, the cells underwent apoptosis and eliminated the damaged cells. Therefore, the MNPs displayed much stronger genotoxicity than the BMs. In summary, the BMs displayed excellent cytocompatibility and reversible genotoxicity toward ARPE-19 cells, indicating great potential for the treatment of ocular diseases.
Methods
Reagents and Materials. The BMs were isolated from M. gryphiswaldense MSR-1 according to a previously published method 19 . MSR-1 strains in logarithmic phase were collected by centrifugation. The cells were resuspended in 10 mL of PBS (0.01 M, pH 7.4), and the cell membranes were disrupted by ultrasonication (SCIENTZ, China) at 300 W. The crude BM extract was collected for 24 h using magnets. The BMs were continuously cleaned by ultrasonication (KQ500D, China) in PBS (0.01 M, pH 7.5) at 100 W for 1 h and collected with magnets for 2-3 h. The ultrasonic cleaning and magnet adsorption steps were repeated until the ultraviolet (UV) absorption of the supernatants was zero at both 260 and 280 nm. The BMs were freeze dried and stored at − 20 °C. The supernatants of each step and the BM membranes were separated by SDS-PAGE and stained with Coomassie blue G250. Han 20 reported that 1 mg of BMs (extracted from wild type MSR-1) contains 0.605 mg of iron, and thus the concentration of BMs was annotated by the iron content in subsequent studies. The iron oxide (II, III) magnetite nanoparticle solution (MNPs, CAS: 1317-61-9) was purchased from Sigma-Aldrich and contained nanoparticles ranging in size from 28 to 32 nm. One milliliter of MNP solution contained 1 mg of iron. For subsequent cell biocompatibility studies, the BMs and MNPs were sterilized by irradiation (15 kGy) 21 and high-pressure steam, respectively.
The BMs and MNPs were characterized by FTIR (Thermo Nicolet 6700) and Zeta Plus (Zetasizer Nano ZS 90), and the magnetic properties were determined with a vibrating sample magnetometer Model 3900 (Princeton Measurements Corporation, USA, sensitivity 5.0 × 10 −10 Am 2 ). The morphologies and sizes of both the BMs and MNPs were observed by HRTEM (JEOL).
Cell Culture. ARPE-19 cells and 661W cells were cultured in DMEM/F12 (Gibco) supplemented with 10% (V/V) qualified fetal bovine serum (Gibco) and gentamicin (50 μ g/mL, Gibco) at 10% CO 2 and 37 °C.
Transmission Electron Microscopy (TEM). ARPE-19 cells were cultured in an incubator with 100 μ g/mL
BMs or MNPs for various times (2, 6, 12, 24, 48 and 72 h). The cells were fixed in 2.5% glutaraldehyde solution as described previously 22 . After embedding, the cells were sliced into ultra-thin sections and stained with toluidine blue for TEM observations. Cell Viability. Cell Counting Kit-8 (CCK-8, Dojindo) was used to determine cell viability. The cells were seeded in 96-well plates at a density of 3,000 cells/well and incubated for 24 h. The cells were cultured in an incubator with various concentrations (10, 50 and 100 μ g/mL) of BMs or MNPs. Cells cultured in medium without BMs or MNPs were used as a negative control. After 24, 48 and 72 h of incubation, the culture medium was replaced with 100 μ L of CCK-8 solution diluted in culture medium at a V/V ratio of 1:10 and incubated for an additional 3 h at 37 °C. The optical density (OD) of each well at 450 nm was recorded by a SpectraMax M5 (Molecular Devices). Cell viability was expressed as the following percentage: (OD test − OD blank )/(OD negative − OD blank ). OD blank was the OD value of culture medium without ARPE-19 cells. The IC50 value was calculated using Bliss's method 23 .
Membrane
Integrity. An LDH test kit (CytoTox 96 ® Non-Radioactive Cytotoxicity Assay, Promega Co.)
was used to evaluate cell membrane integrity. ARPE-19 cells were seeded in 96-well plates (5,000 cells per well) and incubated for 24 h. Then, the cells were treated with various concentrations (10, 50, and 100 μ g/mL) of BMs or MNPs. Cells cultured in medium without BMs or MNPs were used as a negative control. Western Blot. ARPE-19 cells were grown on polystyrene 6-well tissue culture plates at a density of 2.5 × 10 5 cells/well and incubated for 24 h. The cells were continuously cultured in the incubator with various concentrations of BMs or MNPs (10 or 100 μ g/mL) for 24 h. Cells cultured in medium without additives were used as the negative control. The ARPE-19 cells were harvested and lysed in western cracking buffer (Beyotime) for 5 min. The total protein solutions were collected by centrifugation at 14,000 × g for 15 min and concentrated with an Amicon ultra centrifugal filter (Millipore, 0.5 mL, 10 kDa) at 4 °C. The concentrations of the proteins were determined by the BCA Protein Assay Kit (Thermo) according to the instructions provided by the supplier.
Western blots were performed to analyze Bcl-2 or Bax expression levels by probing the membranes with Bcl-2 (Abcam, Cat# ab32124) or Bax (Abcam, Cat# ab32503) rabbit polyclonal antibodies, respectively. The samples were blotted with Goat Anti-Rabbit IgG H&L (HRP) secondary antibodies (Abcam, Cat# ab97051) after the primary antibody incubation. GAPDH was used as the loading control by probing the membrane with the HRP-anti-GAPDH monoclonal antibody (KANGCHEN, Cat# KC-5G5). A chemiluminescent substrate kit (SuperSignal West Dura Extended Duration Substrate, Thermo) was used to detect HRP on the immunoblots. The relative peaks of the bands (normalized to the band of GAPDH) were calculated using Image Lab software (Bio-Rad Laboratories, Inc.).
Statistical analysis.
Six parallel tests were conducted for each condition. All data are presented as the means and standard deviations (means ± SD). Because all data were normally distributed (the skewness and kurtosis values of all data were calculated by SPSS), the significance (p value) was calculated using unpaired, two-tailed Student's t-tests with unequal variance. The symbol "* " denotes statistical significance (* ≤ 0.05, * * ≤ 0.01, * * * ≤ 0.001) compared with the negative control, and p < 0.05 was considered significant.
